Pfizer says pandemic could continue until 2024
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
Pharmaceutical giant Pfizer predicted Friday that the COVID-19 pandemic may not end until 2024, Reuters reports. Also on Friday, the company and its partner BioNTech SE announced plans to delay request for authorization of their COVID-19 vaccine in children ages 2 to 5 "after the shot generated a weaker than expected immune response in a key study," writes The Wall Street Journal.
In a presentation to investors, Pfizer Chief Scientific Officer Mikael Dolsten explained the company "expects some regions to continue to see pandemic levels of COVID-19 cases over the next year or two," per Reuters. Meanwhile, he said, other countries might simultaneously experience COVID on more of an "endemic" level, with "low, manageable caseloads."
By 2024, however, COVID-19 should be endemic globally, Pfizer forecasted.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"When and how exactly this happens will depend on evolution of the disease, how effectively society deploys vaccines and treatments, and equitable distribution to places where vaccination rates are low," Dolsten said. "The emergence of new variants could also impact how the pandemic continues to play out."
Regarding a vaccine for kids ages 2 to 5, Pfzier and BioNTech said they would "begin testing the addition of a third dose in the children, and if successful, would ask U.S. health regulators to authorize use sometime during the first half of 2022," per the Journal.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Can Europe regain its digital sovereignty?Today’s Big Question EU is trying to reduce reliance on US Big Tech and cloud computing in face of hostile Donald Trump, but lack of comparable alternatives remains a worry
-
The Mandelson files: Labour Svengali’s parting gift to StarmerThe Explainer Texts and emails about Mandelson’s appointment as US ambassador could fuel biggest political scandal ‘for a generation’
-
Magazine printables - February 13, 2026Puzzle and Quizzes Magazine printables - February 13, 2026
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
